Linked Life Data

9124019

Source:http://linkedlifedata.com/resource/pubmed/id/9124019

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1997-4-24
pubmed:abstractText
Among the available invasive and noninvasive modalities, nuclear cardiology techniques utilizing single photon emission computerized tomography (SPECT) have achieved a preeminent position for the assessment of myocardial viability. This arises from the rather unique potential of scintigraphic methods to assess myocardial perfusion, cell membrane integrity, and metabolic activity. The purpose of this article is to review the relative merits and limitations of myocardial flow tracers (thallium and sestamibi) and metabolic tracers (fatty acid analogs) to identify residual myocardial viability in patients with coronary artery disease and left ventricular dysfunction.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0001-5385
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
501-14
pubmed:dateRevised
2009-6-11
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Clinical nuclear cardiology: flow tracers and free fatty acid analogs to detect viable myocardium after infarction.
pubmed:affiliation
Academic Hospital, Vrije Universiteit Brussel, Belgium.
pubmed:publicationType
Journal Article, Review